Heart Health Supplements market revenue is projected to grow from USD 10.3 billion in 2026 to USD 18.7 billion by 2036, registering a CAGR of 6.2%. Cholesterol Management applications are expected to hold a dominant 31.8% share, while Omega 3 Fatty Acids will lead the ingredient category with a 34.6% share.